We attended the Annual Meeting of the European Society for Medical Oncology 2017 (ESMO 2017) from 8th to 12th September in Madrid.
More than 23’000 clinicians and researchers participated in the event providing insights and discussing controversial issues in the field. Cooperation between different disciplines such as oncologists, haematologists clinicians and clinical researchers will be key in the area of immunooncology (IO), where complexity is rapidly increasing.
We attended the ASCO 2023 annual meeting in Chicago. After the rise of immuno-oncology, COVID-19 challenged clinical trial execution and muted patient numbers. In the last years we saw many setbacks of once promising immuno-oncology combinations trials.
What mattered this month in healthcare? Q1 reporting came to a close, and FTC action put pressure on the biopharma space and... Find out more in our monthly healthcare newsletter.
With M&A picking up, are we at a turning point for biotech? Check out our latest Kieger AG Chart of the Month Video.